CD38 and acute myeloid leukemia: This model maintains the hierarchical nature of AML where a small population of self-renewing leukemic stem cells (LSC; CD34 + CD38−) differentiate to progenitors (CD34 + CD38 + ), that are unable to sustain long-term self-renewal, and finally to terminally differentiated blasts (CD34-).